AHK-cu 100mg

Copper Peptide for Skin Regeneration and Hair Growth Research

AHK-cu 100mg, is a bioactive short-chain peptide in which a copper ion (Cu ²⁺ ) is coordinated to the tripeptide sequence Alanine–Histidine–Lysine . Present in the blood of most mammals, it plays an important role in regulating the growth , development , and apoptosis of vascular endothelial cells, the cells that line the internal surface of blood vessels. For this reason, it is often referred to as “ copper AHK ” and is the subject of growing interest in advanced cosmetology and trichological research for its potential to improve skin quality and promote hair growth.

Also The primary interest in AHK-Cu concerns its effects on fibroblasts and endothelium . Fibroblasts are the cells responsible for producing and maintaining the extracellular matrix (ECM) , which provides support, tone, and elasticity to tissues; they also secrete factors such as VEGF (Vascular Endothelial Growth Factor) that promote blood vessel growth. In in vitro and animal models, AHK-Cu has been extensively evaluated by the cosmeceutical industry for its effects on skin health , collagen synthesis , and hair growth .

AHK-cu 100mg is a tripeptide in which the copper ion is complexed (chemically bonded) to the Ala–His–Lys sequence. Copper coordinates to three nitrogen atoms in the peptide structure, generating a stable complex capable of interacting with receptors and intracellular signaling pathways. This molecule has been studied as a skin conditioning agent to improve skin appearance and, more recently, as a candidate of interest in hair loss research following promising results in laboratory tests.

AHK-Cu and wrinkle reduction

Copper peptides are widely used in creams and sunscreens for their contribution to skin barrier function and new collagen synthesis . In animal and cellular models, AHK-Cu has been shown to be an effective stimulator of collagen synthesis . Collagen not only provides structure and tension to tissues, but also has the ability to bind water : this increases the hydration of the dermis and ECM, contributing to a smoother appearance and a reduction in the visibility of fine wrinkles .

More so Although AHK-cu 100mg is not a drug and its clinical efficacy requires further validation, in vitro and animal model studies indicate:

• Increased collagen and elastin synthesis in dermal fibroblasts.
• Improved skin elasticity and texture, supporting repair and healing processes .
• Vascular support through endothelial activation and promotion of neoangiogenesis .
• Pro-hair effects related to improved follicular nutrition and protection from stress mediated by TGF-β1-related pathways.

Areas of use and important notes

The properties of AHK-Cu make it suitable for experimental topical formulations in advanced cosmetology and hair research. It can be integrated into serums , lotions , and creams aimed at studying skin regeneration , improving tone and hydration , and scalp well-being . Evaluation in in vitro models and preclinical studies allows for the investigation of dosages, formulation stability, skin penetration, and synergies with other active ingredients (e.g., signaling peptides, antioxidants, and soothing agents).

AHK-cu 100mg, Product intended for external use and research only . It is not intended for the diagnosis, treatment, or prevention of disease; it must not be ingested , injected , or applied to humans or animals outside of strictly experimental settings in accordance with current legislation. Store in suitable conditions, away from light and heat, and use appropriate personal protective equipment during handling.